PL2968446T3 - Sole chlorowodorkowe związku antybiotycznego - Google Patents
Sole chlorowodorkowe związku antybiotycznegoInfo
- Publication number
- PL2968446T3 PL2968446T3 PL14717248T PL14717248T PL2968446T3 PL 2968446 T3 PL2968446 T3 PL 2968446T3 PL 14717248 T PL14717248 T PL 14717248T PL 14717248 T PL14717248 T PL 14717248T PL 2968446 T3 PL2968446 T3 PL 2968446T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrochloride salts
- antibiotic compound
- antibiotic
- compound
- hydrochloride
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003840 hydrochlorides Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779065P | 2013-03-13 | 2013-03-13 | |
| EP14717248.0A EP2968446B1 (en) | 2013-03-13 | 2014-03-06 | Hydrochloride salts of an antibiotic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2968446T3 true PL2968446T3 (pl) | 2017-11-30 |
Family
ID=50483481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14717248T PL2968446T3 (pl) | 2013-03-13 | 2014-03-06 | Sole chlorowodorkowe związku antybiotycznego |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US9161990B2 (pl) |
| EP (1) | EP2968446B1 (pl) |
| JP (3) | JP6482523B2 (pl) |
| KR (1) | KR20150126659A (pl) |
| CN (1) | CN105120883B (pl) |
| AR (1) | AR095044A1 (pl) |
| AU (1) | AU2014241481B9 (pl) |
| BR (1) | BR112015022716A2 (pl) |
| CA (1) | CA2902720A1 (pl) |
| CY (1) | CY1119316T1 (pl) |
| DK (1) | DK2968446T3 (pl) |
| EA (1) | EA027282B1 (pl) |
| ES (1) | ES2633964T3 (pl) |
| GE (1) | GEP20186874B (pl) |
| HR (1) | HRP20171188T1 (pl) |
| HU (1) | HUE033738T2 (pl) |
| IL (1) | IL240663A0 (pl) |
| LT (1) | LT2968446T (pl) |
| MD (1) | MD4599C1 (pl) |
| ME (1) | ME02854B (pl) |
| MX (1) | MX361984B (pl) |
| PH (1) | PH12015502060A1 (pl) |
| PL (1) | PL2968446T3 (pl) |
| PT (1) | PT2968446T (pl) |
| RS (1) | RS56141B1 (pl) |
| SG (1) | SG11201507235YA (pl) |
| SI (1) | SI2968446T1 (pl) |
| SM (1) | SMT201700369T1 (pl) |
| TW (1) | TWI608845B (pl) |
| UA (1) | UA115086C2 (pl) |
| WO (1) | WO2014158952A1 (pl) |
| ZA (1) | ZA201506748B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9796657B2 (en) * | 2015-03-24 | 2017-10-24 | Elevance Renewable Sciences, Inc. | Polyol esters of metathesized fatty acids and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4434287A (en) * | 1975-02-20 | 1984-02-28 | Ciba-Geigy Corporation | Cephalosporin derivatives |
| AR229883A1 (es) | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
| US4626534A (en) | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
| DE3801179A1 (de) | 1988-01-18 | 1989-07-27 | Hoechst Ag | Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten |
| JPH0331449A (ja) | 1989-06-27 | 1991-02-12 | Yamaha Corp | リードフレーム用Ｆｅ―Ｎｉ合金 |
| US5254545A (en) | 1989-09-30 | 1993-10-19 | Eisai Co., Ltd. | Injectable preparations containing cephalosporin medicament |
| JPH03193735A (ja) | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
| JP4142149B2 (ja) | 1997-07-10 | 2008-08-27 | 明治製菓株式会社 | バンコマイシンの凍結乾燥製剤 |
| TWI335332B (en) * | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
| WO2004092183A2 (en) * | 2003-04-16 | 2004-10-28 | Sandoz Ag | Processes for the preparations of cefepime |
| ES2335013T3 (es) | 2003-05-23 | 2010-03-18 | Theravance, Inc. | Antibioticos de glucopeptido-cefalosporina reticulados. |
| US6878868B2 (en) | 2003-06-24 | 2005-04-12 | Mcmillan Stacy L. | Portable high-hat device |
| DE602004012269T2 (de) | 2003-07-11 | 2009-04-30 | Theravance, Inc., South San Francisco | Quervernetzte glycopeptid-cephalosporin-antibiotika |
| TWI342312B (en) | 2003-10-22 | 2011-05-21 | Theravance Inc | Hydrochloride salts of a glycopeptide phosphonate derivative |
| EP1656930A1 (en) | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
| US20080103121A1 (en) | 2006-10-30 | 2008-05-01 | Gole Dilip J | Cephalosporin derivative formulation |
| FR2932177B1 (fr) | 2008-06-06 | 2012-11-30 | Inst Francais Du Petrole | Procede d'hydrogenation selective sur un catalyseur contenant de l'or. |
| JP2010105965A (ja) | 2008-10-30 | 2010-05-13 | Taiyo Yakuhin Kogyo Kk | バンコマイシン製剤 |
| US8431539B2 (en) | 2009-09-17 | 2013-04-30 | Eagle Pharmaceuticals, Inc. | Formulations of daptomycin |
| JP2013511522A (ja) | 2009-11-23 | 2013-04-04 | イーグル・ファーマシューティカルズ・インコーポレーテッド | ダプトマイシン製剤 |
-
2014
- 2014-03-06 MX MX2015012170A patent/MX361984B/es active IP Right Grant
- 2014-03-06 HU HUE14717248A patent/HUE033738T2/hu unknown
- 2014-03-06 SM SM20170369T patent/SMT201700369T1/it unknown
- 2014-03-06 LT LTEP14717248.0T patent/LT2968446T/lt unknown
- 2014-03-06 AU AU2014241481A patent/AU2014241481B9/en not_active Ceased
- 2014-03-06 CA CA2902720A patent/CA2902720A1/en not_active Abandoned
- 2014-03-06 EP EP14717248.0A patent/EP2968446B1/en active Active
- 2014-03-06 ES ES14717248.0T patent/ES2633964T3/es active Active
- 2014-03-06 KR KR1020157027597A patent/KR20150126659A/ko not_active Withdrawn
- 2014-03-06 DK DK14717248.0T patent/DK2968446T3/en active
- 2014-03-06 TW TW103107730A patent/TWI608845B/zh not_active IP Right Cessation
- 2014-03-06 PL PL14717248T patent/PL2968446T3/pl unknown
- 2014-03-06 JP JP2016500713A patent/JP6482523B2/ja active Active
- 2014-03-06 PT PT147172480T patent/PT2968446T/pt unknown
- 2014-03-06 HR HRP20171188TT patent/HRP20171188T1/hr unknown
- 2014-03-06 EA EA201591697A patent/EA027282B1/ru unknown
- 2014-03-06 CN CN201480013969.0A patent/CN105120883B/zh active Active
- 2014-03-06 ME MEP-2017-133A patent/ME02854B/me unknown
- 2014-03-06 US US14/198,956 patent/US9161990B2/en active Active
- 2014-03-06 RS RS20170621A patent/RS56141B1/sr unknown
- 2014-03-06 GE GEAP201413957A patent/GEP20186874B/en unknown
- 2014-03-06 SI SI201430302T patent/SI2968446T1/sl unknown
- 2014-03-06 WO PCT/US2014/021064 patent/WO2014158952A1/en not_active Ceased
- 2014-03-06 SG SG11201507235YA patent/SG11201507235YA/en unknown
- 2014-03-06 UA UAA201509921A patent/UA115086C2/uk unknown
- 2014-03-06 BR BR112015022716A patent/BR112015022716A2/pt not_active Application Discontinuation
- 2014-03-06 MD MDA20150101A patent/MD4599C1/ro active IP Right Grant
- 2014-03-07 AR ARP140100742A patent/AR095044A1/es unknown
-
2015
- 2015-08-18 IL IL240663A patent/IL240663A0/en not_active IP Right Cessation
- 2015-09-11 ZA ZA2015/06748A patent/ZA201506748B/en unknown
- 2015-09-11 PH PH12015502060A patent/PH12015502060A1/en unknown
-
2017
- 2017-02-17 JP JP2017028372A patent/JP2017082016A/ja not_active Withdrawn
- 2017-07-28 CY CY20171100810T patent/CY1119316T1/el unknown
-
2018
- 2018-08-17 JP JP2018153560A patent/JP2018177817A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL243202B (en) | Crystalline inhibitors of bromine sites | |
| IL241186A0 (en) | History of benzaimidazoles as bromodomain inhibitors | |
| EP3026051A4 (en) | Heterocyclic compound | |
| EP2960234A4 (en) | INHIBITING COMPOUND Trk | |
| IL244787A0 (en) | Hydrochloride salt form for ezh2 inhibition | |
| EP3029031A4 (en) | Heterocyclic compound | |
| EP3018123A4 (en) | Amide compound | |
| EP2975031A4 (en) | Heterocyclic compound | |
| EP3061754A4 (en) | Heterocyclic compound | |
| EP2989090A4 (en) | Polymorphic forms of nilotinib hydrochloride | |
| SI3063139T1 (sl) | Heterociklična spojina | |
| IL241962B (en) | Heterocyclic acetamide compound | |
| IL241495A0 (en) | polymorphs and compound salts | |
| ZA201506748B (en) | Hydrochloride salts of an antibiotic compound | |
| IL259981A (en) | Crystalline forms of hydrochloride salts of thienopyrimidine compound |